Impact of C-reactive protein on disease risk and its relation to dietary factors: Literature review

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 2, 2007, Pages 167-177

  Nanri, Akiko ^a   Moore, Malcolm A ^b   Kono, Suminori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UICC Asian Regional Office   (Thailand)

Author keywords

C reactive protein; Diet; Disease risk

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADIPOSE TISSUE; ATHEROSCLEROSIS; BLOOD; COLORECTAL TUMOR; DIET; HUMAN; INFLAMMATION; METABOLISM; PHYSIOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

ADIPOSE TISSUE; ANTIOXIDANTS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; DIET; HUMANS; INFLAMMATION; SENSITIVITY AND SPECIFICITY;

EID: 40449111456     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Ablij H, Meinders A. (2002). C-reactive protein: history and revival. Eur J Intern Med, 13, 412.
2. Abramson J L, Hooper W C, Jones D P, et al. (2005). Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis, 178, 115-21.
3. Albert M A, Glynn R J, Ridker P M. (2003). Alcohol consumption and plasma concentration of C-reactive protein. Circulation, 107, 443-7.
4. Anderson J W, Johnstone B M, Cook-Newell M E. (1995). Metaanalysis of the effects of soy protein intake on serum lipids. N Engl J Med, 333, 276-82.
5. Averina M, Nilssen O, Arkhipovsky V L, et al. (2006). C-reactive protein and alcohol consumption: Is there a U-shaped association? Results from a population-based study in Russia. The Arkhangelsk study. Atherosclerosis, 188, 309-15.
6. Balkwill F, Mantovani A. (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539-45.
7. Barzilay J I, Abraham L, Heckbert S R, et al. (2001). The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 50, 2384-9.
8. Bazzano L A, He J, Muntner P, et al. (2003). Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med, 138, 891-7.
9. Bertran N, Camps J, Fernandez-Ballart J, et al. (2005). Diet and lifestyle are associated with serum C-reactive protein concentrations in a population-based study. J Lab Clin Med, 145, 41-6.
10. Block G, Jensen C, Dietrich M, et al. (2004). Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr, 23, 141-7.
11. Bo S, Durazzo M, Guidi S, et al. (2006). Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr, 84, 1062-9.
12. Boekholdt S M, Meuwese M C, Day N E, et al. (2006). Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study. Br J Nutr, 96, 516-22.
13. Brighenti F, Valtueña S, Pellegrini N, et al. (2005). Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of highsensitivity C-reactive protein in adult Italian subjects. Br J Nutr, 93, 619-25.
14. Bruunsgaard H, Poulsen H E, Pedersen B K, et al. (2003). Longterm combined supplementations with alpha-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men. J Nutr, 133, 1170-3.
15. Calder P C. (2006). n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr, 83, 1505S-19S.
16. Choi E Y, Park E H, Cheong Y S, et al (2006). Association of Creactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism, 55, 415-21
17. Church T S, Earnest C P, Wood K A, Kampert J B. (2003). Reduction of C-reactive protein levels through use of a multivitamin. Am J Med, 115, 702-7.
18. Coussens L M, Werb Z. (2002). Inflammation and cancer. Nature, 420, 860-7.
19. Danesh J, Collins R, Appleby P, et al. (1998). Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Jama, 279, 1477-82.
20. Danesh J, Wheeler J G, Hirschfield G M, et al. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 350, 1387-97.
21. Danna R, Baviera G, Corrado F, et al. (2005). The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand, 84, 474-7.
22. Dehghan A, Kardys I, de Maat M P, et al. (2007). Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes, 56, 872-8.
23. Devaraj S, Jialal I. (2000). Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med, 29, 790-2.
24. Dietrich M, Jialal I. (2005). The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev, 63, 22-8.
25. Doi Y, Kiyohara Y, Kubo M, et al. (2005). Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care, 28, 2497-500.
26. Duncan B B, Schmidt M I, Pankow J S, et al. (2003). Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes, 52, 1799-805.
27. Eckel R H, Grundy S M, Zimmet P Z. (2005). The metabolic syndrome. Lancet, 365, 1415-28.
28. Eilertsen A L, Hoibraaten E, Os I, et al. (2005). The effects of oral and transdermal hormone replacement therapy on Creactive protein levels and other inflammatory markers in women with high risk of thrombosis. Maturitas, 52, 111-8.
29. Endres S, Ghorbani R, Kelley V E, et al. (1989). The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med, 320, 265-71.
30. Erlinger T P, Platz E A, Rifai N, et al. (2004). C-reactive protein and the risk of incident colorectal cancer. Jama, 291, 585-90.
31. Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. (2006). Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr, 84, 1489-97.
32. Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. (2007). Dietary Patterns and Markers of Systemic Inflammation among Iranian Women. J Nutr, 137, 992-8.
33. Festa A, Dagostino R Jr., Tracy R P, et al. (2002). Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes, 51, 1131-7.
34. Ford E S, Liu S, Mannino D M, et al. (2003). C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr, 57, 1157-63.
35. Fredrikson G N, Hedblad B, Nilsson J A, et al. (2004). Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism, 53, 1436-42.
36. Freeman D J, Norrie J, Caslake M J, et al. (2002). C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51, 1596-600.
37. Frohlich M, Imhof A, Berg G, et al. (2000). Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care, 23, 1835-9.
38. Fujioka S, Hamazaki K, Itomura M, et al. (2006). The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects--A randomized, placebocontrolled, double-blind study. J Nutr Sci Vitaminol, 52, 261-5.
39. Fung T T, Rimm E B, Spiegelman D, et al. (2001). Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr, 73, 61-7.
40. Gao X, Bermudez O I, Tucker K L. (2004). Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr, 134, 913-8.
41. Guerrero-Romero F, Rodríguez-Morán M. (2002). Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord, 26, 469-74.
42. Gunter M J, Stolzenberg-Solomon R, Cross A J, et al. (2006). A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res, 66, 2483-7.
43. Hall W L, Vafeiadou K, Hallund J, et al. (2005). Soy-isoflavoneenriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr, 82, 1260-8; quiz 1365-6.
44. Hamilton I M, Gilmore W S, Benzie I F, et al. (2000). Interactions between vitamins C and E in human subjects. Br J Nutr, 84, 261-7.
45. Han T S, Sattar N, Williams K, et al. (2002). Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care, 25, 2016-21.
46. Heidemann C, Hoffmann K, Spranger J, et al. (2005). A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort. Diabetologia, 48, 1126-34.
47. Hoffmann K, Zyriax B C, Boeing H, et al. (2004). A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease. Am J Clin Nutr, 80, 633-40.
48. Hu F B, Meigs J B, Li T Y, Rifai N, Manson J E. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes, 53, 693-700.
49. Il'yasova D, Colbert L H, Harris T B, et al. (2005). Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev, 14, 2413-8.
50. Ito Y, Suzuki K, Tamakoshi K, et al. (2005). Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study. J Epidemiol, 15 Suppl 2, S185-9.
51. Jaye D L, Waites K B. (1997). Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J, 16, 735-46; quiz 746-7.
52. Jenkins D J, Kendall C W, Connelly P W, et al. (2002). Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism, 51, 919-24.
53. Kant A K. (2004). Dietary patterns and health outcomes. J Am Diet Assoc, 104, 615-35.
54. Karin M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature, 441, 431-6.
55. Kaul N, Devaraj S, Grundy S M, Jialal I. (2001). Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects. Am J Cardiol, 87, 1320-3.
56. King D E, Egan B M, Geesey M E. (2003). Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol, 92, 1335-9.
57. King D E, Mainous A G III, Egan B M, Woolson R F, Geesey M E. (2005). Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care, 28, 1487-9.
58. Kobayashi S, Inoue N, Ohashi Y, et al. (2003). Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol, 23, 1398-404.
59. Kolb-Bachofen V. (1991). A review on the biological properties of C-reactive protein. Immunobiology., 183, 133-45.
60. Kuo H K, Yen C J, Chen J H, Yu Y H, Bean J F. (2007). Association of cardiorespiratory fitness and levels of Creactive protein: data from the National Health and Nutrition Examination Survey 1999-2002. Int J Cardiol, 114, 28-33.
61. Laaksonen D E, Niskanen L, Nyyssonen K, et al. (2004). Creactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia, 47, 1403-10.
62. Lakoski S G, Cushman M, Criqui M, et al. (2006). Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J, 152, 593-8.
63. Leichtle A, Teupser D, Thiery J. (2006). Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects. J Am Coll Nutr, 25, 420-8.
64. Li J J, Fang C H. (2004). C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses, 62, 499-506.
65. Libby P, Ridker P M. (2004). Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med, 116 Suppl 6A, 9S-16S.
66. Liu S, Stampfer M J, Hu F B, et al. (1999). Whole-grain consumption and risk of coronary heart disease: results from the Nurses Health Study. Am J Clin Nutr, 70, 412-9.
67. Lopez-Garcia E, Schulze M B, Fung T T, et al. (2004). Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr, 80, 1029-35.
68. Lopez-Garcia E, Schulze M B, Manson J E, et al. (2004). Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr, 134, 1806-11.
69. Lowe G D, Upton M N, Rumley A, et al. (2001). Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey. Thromb Haemost, 86, 550-6.
70. Manns P J, Williams D P, Snow C M, Wander R C. (2003). Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement. Am J Hum Biol, 15, 91-100.
71. McMillan D C, Talwar D, Sattar N, et al. (2002). The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr, 21, 161-4.
72. Meier-Ewert H K, Ridker P M, Rifai N, et al. (2001). Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem, 47, 426-30.
73. Mezzano D, Munoz X, Martinez C, et al. (1999). Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine. Thromb Haemost, 81, 913-7.
74. Miki C, Konishi N, Ojima E, et al. (2004). C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci, 49, 970-6.
75. Mori T A, Beilin L J. (2004). Omega-3 fatty acids and inflammation. Curr Atheroscler Rep, 6, 461-7.
76. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N. (2003). Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care, 26, 2754-7.
77. Nettleton J A, Steffen L M, Mayer-Davis E J, et al. (2006). Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr, 83, 1369-79.
78. Newby P K, Tucker K L. (2004). Empirically derived eating patterns using factor or cluster analysis: a review. Nutr Rev, 62, 177-203.
79. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. (1998). Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg, 176, 335-8.
80. Ockene I S, Matthews C E, Rifai N, et al. (2001). Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem, 47, 444-50.
81. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. (2006). Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev, 15, 690-5.
82. Pearson T A, Mensah G A, Alexander R W, et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499-511.
83. Pellegrini N, Serafini M, Colombi B, et al. (2003). Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr, 133, 2812-9.
84. Pepys M B. (2005). CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol, 25, 1091-4.
85. Pepys M B, Hirschfield G M. (2003). C-reactive protein: a critical update. J Clin Invest, 111, 1805-12.
86. Pischon T, Hankinson S E, Hotamisligil G S, et al. (2003). Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation, 108, 155-60.
87. Pradhan A D, Manson J E, Rifai N, et al. (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 286, 327-34.
88. Pradhan A D, Manson J E, Rossouw J E, et al. (2002). Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Womens Health Initiative observational study. JAMA, 288, 980-7.
89. Pryor W A. (2000). Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med, 28, 141-64.
90. Qi L, van Dam R M, Liu S, et al. (2006). Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care, 29, 207-11.
91. Ridker P M. (2001). High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 103, 1813-8.
92. Ridker P M, Buring J E, Cook N R, et al. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation, 107, 391-7.
93. Rifai N, Buring J E, Lee I M, et al. (2002). Is C-reactive protein specific for vascular disease in women? Ann Intern Med, 136, 529-33.
94. Rodríguez-Morán M, Guerrero-Romero F. (2003). Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care, 26, 1147-52.
95. Ross R. (1999). Atherosclerosis--an inflammatory disease. N Engl J Med, 340, 115-26.
96. Salmeron J, Manson J E, Stampfer M J, et al. (1997). Dietary fiber, glycemic load, and risk of non-insulin-dependent
97. Scheurig A C, Thorand B, Fischer B, et al. (2007). Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/ KORA Augsburg study. Eur J Clin Nutr.
98. Schulze M B, Hoffmann K, Manson J E, et al. (2005). Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr, 82, 675-84; quiz 714-5.
99. Selvin E, Paynter N P, Erlinger T P. (2007). The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med, 167, 31-9.
100. Shechter M, Sharir M, Labrador M J, et al. (2000). Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation, 102, 2353-8.
101. Shine B, de Beer F C, Pepys M B. (1981). Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta, 117, 13-23.
102. Siemes C, Visser L E, Coebergh J W, et al. (2006). C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol, 24, 5216-22.
103. Song Y, Ridker P M, Manson J E, et al. (2005). Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care, 28, 1438-44.
104. Spranger J, Kroke A, Mohlig M, et al. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes, 52, 812-7.
105. Suzuki K, Ito Y, Ochiai J, et al. (2003). Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev, 4, 259-66.
106. Szeto Y T, Kwok T C, Benzie I F. (2004). Effects of a long-term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk. Nutrition, 20, 863-6.
107. Taylor K E, Giddings J C, van den Berg C W. (2005). C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol, 25, 1225-30.
108. Thorand B, Lowel H, Schneider A, et al. (2003). C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med, 163, 93-9.
109. Tillett W S, Francis T. (1930). Serological reactions in pneumonia with a non-protein somatic fraction of the pneumococcus. J Exp Med, 52, 561-71.
110. Timpson N J, Lawlor D A, Harbord R M, et al. (2005). C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet, 366, 1954-9.
111. Trichopoulos D, Psaltopoulou T, Orfanos P, et al. (2006). Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev, 15, 381-4.
112. Ullegaddi R, Powers H J, Gariballa S E. (2006). Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial. JPEN J Parenter Enteral Nutr, 30, 108-14.
113. Upritchard J E, Sutherland W H, Mann J I. (2000). Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care, 23, 733-8.
114. Valtueña S, Del Rio D, Pellegrini N, et al. (2007). The total antioxidant capacity of the diet is an independent predictor of plasma beta-carotene. Eur J Clin Nutr, 61, 69-76.
115. van Herpen-Broekmans W M, Klopping-Ketelaars I A, Bots M L, et al. (2004). Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol, 19, 915-21.
116. Visser M, Bouter L M, McQuillan G M, et al. (1999). Elevated C-reactive protein levels in overweight and obese adults. JAMA, 282, 2131-5.
117. Volpato S, Pahor M, Ferrucci L, et al. (2004). Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation, 109, 607-12.
118. Wannamethee S G, Lowe G D, Rumley A, Bruckdorfer K R, Whincup P H. (2006). Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr, 83, 567-74; quiz 726-7.
119. Watzl B, Kulling S E, Moseneder J, Barth S W, Bub A. (2005). A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr, 82, 1052-8.
120. Woollard K J, Rayment S J, Bevan R, et al. (2006). Alphatocopherol supplementation does not affect monocyte endothelial adhesion or C-reactive protein levels but reduces soluble vascular adhesion molecule-1 in the plasma of healthy subjects. Redox Rep, 11, 214-22.
121. Wu J H, Ward N C, Indrawan A P, et al. (2007). Effects of alphatocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin Chem, 53, 511-9.
122. Zampelas A, Panagiotakos D B, Pitsavos C, et al. (2005). Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J Am Coll Cardiol, 46, 120-4.
123. Zhang S M, Buring J E, Lee I M, Cook N R, Ridker P M. (2005). C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med, 142, 425-32.